The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Stephen P. Griggs net worth and biography

Stephen Griggs Biography and Net Worth

CEO of AdaptHealth

Steve Griggs was named CEO of AdaptHealth in June 2021. He joined the Company as co-CEO following the 2021 acquisition of AeroCare. Mr. Griggs founded AeroCare in 2000 and led the organization as CEO. Prior to AeroCare, Mr. Griggs served as CFO, COO and President of Rotech Medical Corporation. He began his career as a CPA and later served as controller for a tourist and entertainment conglomerate in Orlando, FL, where he led the financial turnaround efforts. Mr. Griggs holds a B.S.B.A in Business Management from East Tennessee State University and a B.S.B.A. in Accounting from University of Central Florida.

What is Stephen P. Griggs' net worth?: The estimated net worth of Stephen P. Griggs is at least $39,840.00 as of May 20th, 2021. Mr. Griggs owns 4,000 shares of AdaptHealth stock worth more than $39,840 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Griggs may own. Learn More about Stephen P. Griggs' net worth.
How do I contact Stephen P. Griggs?: The corporate mailing address for Mr. Griggs and other AdaptHealth executives is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. AdaptHealth can also be reached via phone at (610) 424-4515 and via email at [email protected]. Learn More on Stephen P. Griggs' contact information.
Has Stephen P. Griggs been buying or selling shares of AdaptHealth?: Stephen P. Griggs has not been actively trading shares of AdaptHealth during the last ninety days. Most recently, on Thursday, March 3rd, Stephen P. Griggs bought 32,342 shares of AdaptHealth stock. The stock was acquired at an average cost of $15.44 per share, with a total value of $499,360.48. Learn More on Stephen P. Griggs' trading history.
Who are AdaptHealth's active insiders?: AdaptHealth's insider roster includes Jason Clemens (CFO), Stephen Griggs (CEO), Ronald Mcdaniel (Director), Frank Mullen (CAO), Alan Quasha (Director), Shaw Rietkerk (COO), and Dale Wolf (Director). Learn More on AdaptHealth's active insiders.
Are insiders buying or selling shares of AdaptHealth?: In the last year, AdaptHealth insiders bought shares 1 times. They purchased a total of 720 shares worth more than $10,152.00. In the last year, insiders at the sold shares 5 times. They sold a total of 527,501 shares worth more than $6,709,619.15. The most recent insider tranaction occured on March, 11th when Major Shareholder James E Flynn sold 182,607 shares worth more than $2,012,329.14. Insiders at AdaptHealth own 13.6% of the company. Learn More about insider trades at AdaptHealth.
Information on this page was last updated on 3/11/2024.

Stephen P. Griggs Insider Trading History at AdaptHealth

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2022	Buy	32,342	$15.44	$499,360.48
11/30/2021	Buy	50,000	$19.42	$971,000.00
5/20/2021	Buy	4,000	$24.14	$96,560.00	4,000

Stephen P. Griggs Buying and Selling Activity at AdaptHealth

AdaptHealth Company Overview

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $9.96

$9.59

$9.96

50 Day Range

MA: $10.00

$7.10

$11.51

2 Week Range

Now: $9.96

$6.37

$15.37

Volume

1,053,761 shs

Average Volume

1,082,691 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Move Your Money Before May 22

From Stansberry Research | Ad